BSE filing, NSE: GALAXYSURF. Summary written from the filing by ALFA Finder's alert engine.
Galaxy Surfactants Ltd: key numbers
- Share price
- ₹2,167.00
- Market cap
- ₹7,685 Cr
- Revenue (annual)
- ₹5,248 Cr
- Net profit (annual)
- ₹267.4 Cr
- P/E (TTM)
- 21.7×Sector 34.5×
- Promoter holding
- 70.90%+0.00% QoQ
- FII holding
- 3.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Galaxy Surfactants Ltd
All →Galaxy Surfactants Annual General Meeting
Galaxy Surfactants Ltd has issued a Postal Ballot notice for shareholder approval of two key resolutions. These include appointing Mr. Uday K. Kamat as Director and approving a related-party transaction.
- Value
- ₹1.54 Cr
- Execution
- 3 years
Galaxy Surfactants Annual General Meeting
Galaxy Surfactants filed a postal ballot notice seeking approval for a subsidiary director appointment and a new Non-Executive Director. E-voting runs October 19 to November 17, 2026.
Galaxy Surfactants Other Announcement
Galaxy Surfactants Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31 disclosure requirements.
Galaxy Surfactants Management Change
Galaxy Surfactants Ltd has appointed Uday K. Kamat as an Additional Non-Executive, Non-Independent Director, effective October 05, 2026, subject to shareholder approval.
Galaxy Surfactants Partnership
Galaxy Surfactants Ltd. signed a Partnership Growth Charter with Unilever to accelerate next-generation surfactant technologies. The collaboration focuses on bio-based alternatives and lower-carbon technologies for future growth.
Galaxy Surfactants Investor Presentation: Key Takeaways
Galaxy Surfactants delivered a strong Q1FY27 performance with consolidated revenue growing 39.4% YoY and EBITDA surging 86.9%. Growth was driven by a return to double-digit volumes in India and Specialty Care recovery.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.